WuXi AppTec | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights
WuXi AppTec is a global company headquartered in Shanghai, providing a comprehensive range of R&D and manufacturing services to the...
WuXi AppTec is a global company headquartered in Shanghai, providing a comprehensive range of R&D and manufacturing services to the pharmaceutical and biotech industries. With operations across Asia, Europe, and North America, the company supports over 6,000 customers in advancing healthcare products through integrated services that include drug discovery, clinical research, and advanced therapies. WuXi AppTec aims to enable every drug to be made and every disease to be treated, receiving recognition for its commitment to sustainability and innovation.
Website
Headquarters
Shanghai, Shanghai
Size
10,001+ employees
Industry
Pharmaceutical Manufacturing
Specialities
Drug Discovery, Bioanalytical, Lab Testing, Clinical and Regulatory, API Development and Manufacturing, Drug Development, Biological Reagents, Biologics, Medical Device, Chemistry, Toxicology, Cell and Gene Therapy, Contract Research Organization
🛍️ WuXi AppTec Product and Pricing News →
👔 WuXi AppTec CEO, Management and Leadership Team →
⚔️ WuXi AppTec Alternatives and Competitors →
💼 WuXi AppTec Hiring and Layoffs →
🤖 WuXi AppTec Developer, Integration and Automation News →
📈 WuXi AppTec Financials, Fundraising and Valuation News →
🛍️ WuXi AppTec Product and Pricing News
- WuXi AppTec opened its first high potency oral drug product manufacturing facility in 2022, expanding its integrated drug product R&D and manufacturing services.
- WuXi AppTec has upgraded its OncoWuXi database to version 3.0, enhancing user experience and expanding its functionality and scope.
- WuXi AppTec opened a new R&D center in Changzhou, China on November 15, 2024.
- WuXi AppTec has updated its location details and services across various cities in China, including Shanghai, Changzhou, Suzhou, Nanjing, Nantong, Wuxi, and Chengdu, with specific focus on drug discovery, CDMO services, and cell therapy.
- At SITC 2024, WuXi AppTec presented a poster on using imiquimod to induce psoriasis-like symptoms in NHPs to aid in evaluating psoriasis treatments.
- WuXi AppTec's Couvet site in Switzerland received a 2024 silver medal from EcoVadis for its sustainability efforts, ranking in the top 9% of all rated companies.
- WuXi AppTec has been ranked #1 in the global Life Sciences Tools & Services sector in the 2024 S&P Global Corporate Sustainability Assessment as of November 11, 2024.
- WuXi AppTec will exhibit at the EBF 2024 Open Symposium in Barcelona from November 20-22, showcasing two poster presentations on antibody detection methods.
👔 WuXi AppTec CEO, Management and Leadership Team
-
Director
[email protected] -
Director, Project Management[email protected]
-
Director EU Chemistry Operations[email protected]
-
Director Discovery Biology[email protected]
-
Director[email protected]
-
Sr Director, Business Development[email protected]
-
SVP & Chief Digital Officer[email protected]
-
Vice President, Chief Scientific Toxicologist, WuXi AppTec (Suzhou) Co., Ltd.
-
Chief Strategy Officer[email protected]
-
Senior Director Operations and Biocompatibility
-
Vice President, Research Service Division[email protected]
-
Senior Vice President, Head of RCS BD&IPM, WuXi Chemistry[email protected]
-
Vice President Reagent product & Service[email protected]
-
Vice President, DDSU, WuXi AppTech[email protected]
-
Vice President and Head of Content Division[email protected]
-
Vice President, Synthetic Chemistry[email protected]
-
Vice President of International Discovery Service Unit (IDSU) China Western Region WuXi AppTec[email protected]
-
CEO of STA, a WuXi AppTec Company[email protected]
-
Co-CEO[email protected]
⚔️ WuXi AppTec Alternatives and Competitors
- Medicines Discovery Catapult |
- Arctoris |
- Recipharm |
- Covance |
- Charles River |
- Parexel |
- wuxibiologics.com |
- wuxibiology.com |
- medicilon.com.cn |
- yangzijiang.com |
- Eurofins Scientific |
- Aptar |
- Pace Analytical Life Sciences |
- BGI Genomics |
- Pharmaron |
- Syngene International |
- KBI BioPharma |
- Precigen |
- Sai Life Sciences |
- ElexoPharm |
- Renovo Research |
- Informatics Outsourcing |
- Biotrend
💼 WuXi AppTec Hiring and Layoffs
- Emma Quirk has joined WuXi AppTec as Director, CMC, EU in the Greater Liverpool Area, previously serving as Director at Biohaven Pharmaceuticals.
- Robert Cissell has joined WuXi AppTec as Sr. Director Business Development in the Louisville Metropolitan Area, previously holding a position in a similar role.
- WuXi AppTec is currently hiring for the position of Associate Director Project Management Oligo and Peptide in the United States.
- Silvia Guatelli has joined WuXi AppTec as an Associate Senior Scientist II.
- Kyle Thomas has been promoted to Senior Laboratory Technician at WuXi AppTec.
🤖 WuXi AppTec Developer, Integration and Automation News
📈 WuXi AppTec Financials, Fundraising and Valuation News
- WuXi AppTec will hold its Q3 2024 earnings call on November 18 with participation from Co-CEOs Dr. Minzhang Chen and Dr. Qing Yang, CFO Ms. Ming Shi, and other executives.
- WuXi AppTec is a key investor in MEGAROBO's recent C-Financing round.
- WuXi AppTec reported its fourth consecutive year-over-year revenue decline in the third quarter, with earnings at 10.46 billion Chinese yuan.
- WuXi AppTec experienced its fourth consecutive quarter of revenue decline amid concerns over the BIOSECURE Act.
People also viewed
